EP3986561
PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
:
EP einkaleyfi í gildi á Íslandi:
17.6.2020:
14.2.2024:
20743783.1
:
27.3.2024:
15.5.2024
:
16.6.2040:
16.6.2026:
30.6.2026
:
PYRIDO[2,3-D]PYRIMIDINE DERIVATIVES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
17.6.2020
14.2.2024
27.3.2024
15.5.2024
16.6.2026
:
VIIV Healthcare UK (No.5) Limited:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
:
GILLIS, Eric P:
Branford, Connecticut 06405, US
:
IWUAGWU, Christiana:
Wallingford, Connecticut 06492, US
:
201962863406 P:
19.6.2019:
US
:
IB2020055653:
17.6.2020
:
A61P 31/18, C07D 471/04, A61K 31/519
: 5
: 23.5.2024
: 16.6.2025
: Árnason Faktor ehf.
: 6
: 12.6.2025
: 16.6.2026
: Árnason Faktor ehf.